Drupal.behaviors.print = function(context) {window.print();window.close();}>
Trovagene Prices Public Offering as it Effects Reverse Stock Split and Moves to Nasdaq
May 30, 2012
Trovagene Prices Public Offering as it Effects Reverse Stock Split and Moves to Nasdaq
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
Trovagene's Q4 Revenues, Loss Rise
April 2, 2013 / GenomeWeb Daily News
Novartis' Genoptix Licenses Trovagene Marker for AML Services
December 20, 2012 / GenomeWeb Daily News
Trovagene Teams with Brazilian Partner on HPV Test Evaluation
November 27, 2012 / GenomeWeb Daily News
Trovagene Closes $3.8M Private Placement
November 23, 2012 / GenomeWeb Daily News